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Background: Kindler Syndrome (KS) is an autosomal recessive skin disorder characterized by skin blistering,
photosensitivity, premature aging, and propensity to skin cancer. In spite of the knowledge underlying cause of this
disease involving mutations of FERMT1 (fermitin family member 1), and efforts to characterize genotype-phenotype
correlations, the clinical variability of this genodermatosis is still poorly understood. In addition, several pathognomonic
features of KS, not related to skin fragility such as aging, inflammation and cancer predisposition have been strongly
associated with oxidative stress. Alterations of the cellular redox status have not been previously studied in KS. Here we
explored the role of oxidative stress in the pathogenesis of this rare cutaneous disease.
Methods: Patient-derived keratinocytes and their respective controls were cultured and classified according to their
different mutations by PCR and western blot, the oxidative stress biomarkers were analyzed by spectrophotometry and
qPCR and additionally redox biosensors experiments were also performed. The mitochondrial structure and
functionality were analyzed by confocal microscopy and electron microscopy.
Results: Patient-derived keratinocytes showed altered levels of several oxidative stress biomarkers including MDA
(malondialdehyde), GSSG/GSH ratio (oxidized and reduced glutathione) and GCL (gamma-glutamyl cysteine ligase)
subunits. Electron microscopy analysis of both, KS skin biopsies and keratinocytes showed marked morphological
mitochondrial abnormalities. Consistently, confocal microscopy studies of mitochondrial fluorescent probes confirmed
the mitochondrial derangement. Imbalance of oxidative stress biomarkers together with abnormalities in the
mitochondrial network and function are consistent with a pro-oxidant state.
Conclusions: This is the first study to describe mitochondrial dysfunction and oxidative stress involvement in KS.
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Kindler Syndrome (KS; OMIM 173650; ORPHA 2908), a
rare heritable skin disorder with a complex phenotype
and poorly understood pathogenesis, is characterized
clinically by acral skin blisters in infancy and childhood,
photosensitivity, and progressive poikiloderma [1-3].
Additional clinical features include chronic gingival ero-
sions, oesophageal and urethral stenosis as well as high
risk of mucocutaneous malignancies [1].* Correspondence: federico.v.pallardo@uv.es; marcela.delrio@uc3m.es
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article, unless otherwise stated.KS results from recessive loss-of-function mutations in
the FERMT1 (fermitin family member 1) gene that en-
codes the protein kindlin-1, a component of focal adhe-
sions in epithelial cells [2,3]. This protein mediates
anchorage between the actin cytoskeleton and the
extracellular matrix via focal adhesions, playing an im-
portant role in keratinocyte migration, proliferation and
adhesion [4-7].
Although genetic mutations in FERMT1 have been
identified as the origin of this disease, the complex pheno-
type of KS cannot be exclusively explained based on the
adhesive function of kindlin-1. Therefore, the mechanisms
responsible for clinical features such as photosensitivity
and cancer are still awaiting to be unveiled [8]. Severald Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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gility such as aging, inflammation and cancer have been
strongly associated to oxidative stress [9]. Reactive oxy-
gen species (ROS) are produced continuously in tissues
as part of normal cell functions. However, the excessive
production of ROS induces DNA and other macromole-
cules damage [9-11]. To counteract the excessive produc-
tion of ROS, mammalian cells have developed several
mechanisms of detoxification, located in specific subcellu-
lar compartments [12]. These include non-enzymatic anti-
oxidants such as glutathione (GSH) and enzymes with
antioxidant properties (e.g. catalase and superoxide dis-
mutases) [9,13]. Glutathione is one of the main antioxi-
dant molecules with a role in ROS detoxification and the
biochemical systems involved in their synthesis and recov-
ery (glutathione reductase and glutathione peroxidase) are
important to maintain the cell in a physiologic redox sta-
tus [14,15].
In this study we sought to analyse at both, cellular and
molecular levels, the potential derangements of the redox
status in KS skin and keratinocytes. Using a variety of bio-
chemical, molecular and morphological approaches we
were able to detect an imbalance of oxidative stress bio-
markers and mitochondrial abnormalities consistent with
a pro-oxidant state in KS. Our results provide pathological




Skin biopsies were taken from non-affected areas of KS
patients’ arm, in which mutations, ages and gender are de-
tailed in (Additional file 1: Table S1). Patient informed
consents were obtained in agreement with the collabora-
tive centres, where biopsies and blood samples were ob-
tained. The Ethics Committee of Fundación Jiménez Díaz
(Madrid, Spain) evaluated and approved this research,
stating that the procedures followed were in accordance
with the institutional ethical standards on human experi-
mentation and the project adheres to the Helsinki Guide-
lines and further reviews including Seul 2008.
Electron microscopy
For Electron Microscopy, cell cultures were fixed with
3.5% glutaraldehyde while biopsies were fixed with 2%
paraformaldehyde and 2.5% glutaraldehyde solution by
immersion. All samples were post-fixed in 2% osmium
and dehydrated through an ascending series of ethanol
concentrations. They were then stained with 2% uranyl
acetate in 70% ethanol for 2 hours and embedded in
Durcupan resin (Fluka BioChemika, Ronkokoma, NY,
USA). Ultrathin sections (70 nm) were cut, stained with
Reynolds’ lead citrate and examined under a Transmis-
sion Electron Microscope (FEI Tecnai G2 Spirit, FEIEurope, Eindhoven, Netherlands) using a digital camera
(Morada, Soft Imaging System, Olympus, Japan). To iden-
tify the ultrastructural differences between patients’ skin
specimens and controls, 10 randomized cells from 10 ran-
domized areas of each cell culture were analyzed. Skin bi-
opsies were obtained from control and KS patients and
ten randomized mitochondria from eight keratinocytes
were analyzed for each sample.
Mutational analysis
Intronic primer pairs were designed to amplify individual
exons and flanking splice sites of the FERMT1 gene. Poly-
merase Chain Reaction (PCR) amplification of FERMT1
gene was performed on genomic DNA as previously de-
scribed [2,16]. PCR products were directly sequenced in
both orientations in an ABI Prism 3730 genetic analyzer
(Life Technologies/Applied Biosystems).
Primary keratinocyte culture
Skin biopsies were incubated two hours at room
temperature with collagenase (Sigma) (0.25% diluted in
DMEM (Gibco, Life Technologies)). Detached epidermal
sheet was then incubated with tryspin solution (Sigma)
for 20 minutes at 37°C (four cycles of trypsin were
done). The released keratinocytes were centrifuged at
1000 rpm for 7 minutes [17,18]. The cell pellet was resus-
pended in keratinocyte medium: 3:1 mixture of Dulbecco’s
modified Eagle medium (DMEM) (GIBCO-BRL) and
HAM’s F12 (Gibco, Life Technologies), containing 10%
fetal calf serum replacement (Fetal Clone II, Hyclone-
Lonza). This medium was supplemented as previously
described [19,20]. Keratinocytes were plated in T75
flasks previously seeded with a feeder layer of lethally
irradiated (X-ray; 50 Gy) 3 T3-J2 cells (a gift from Dr J.
Garlick, SUNY, Stony Brook, NY) as previously described
[21], for western blot and redox biosensors experiments.
In contrast, for oxidative stress markers, confocal micros-
copy and electron microscopy experiments cells were cul-
tured in Cnt-BM.1 Basal Medium (CellNTec) in feeder
layer free conditions. Cells were cultured at 37°C in a
humid atmosphere containing 5% CO2 and the culture
medium was changed every other day. Third to fifth pas-
sages cells were used as indicated for all experiments.
Measurement of lipid peroxides
Lipid peroxides were determined by measuring MDA,
which is formed from such peroxides. MDA from the
samples reacted with thiobarbituric acid (TBA) at 100°C
to form a MDA-TBA adduct. The protein-free extract was
separated by HPLC (Ultimate 3000 Bionex) on a column
of octadecyl silica gel (C16, Bionex) to separate the MDA-
TBA adduct from interfering chromogens. The adduct
was eluted from the column with 50 mM phosphate
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photometrically at 532 nm.
Measurement of GSSG/GSH ratio
GSH and GSSG levels were studied using the Glutathione
Fluorescent Detection Kit (Arbor Assays, Ann Arbor,
Michigan USA) following the instructions of manufac-
turers for cellular material. Briefly, cells were prepared
in 5% sulphosalicilic acid and centrifuged at 13,000 g to
separate the proteins. The supernatant containing the
GSH and GSSG was reacted with ThioStarreagent to
produce a fluorescent product (λ emission 510 nm, λ
excitation 390 nm). Addition to the sample of a reac-
tion mixture containing NADPH and GSH reductase
converts all the GSSG into free GSH, which then reacts
with ThioStar, yielding the signal corresponding to total
GSH. The difference between both measures offers the
amount of GSSG.
qPCR
Total RNA was isolated from cells using the PARISTM
Protein and RNA Isolation System (Ambion; Austin, TX)
according to the manufacturer’s instructions. For reverse
transcription reactions (RT), 1 μg of the purified RNA was
reverse transcribed using random hexamers with the
High-Capacity cDNA Archive kit (Applied Biosystems,
Foster City, CA) according to the manufacturer’s instruc-
tions. RT conditions comprised an initial incubation step
at 25°C for 10 min to allow random hexamers annealing,
followed by cDNA synthesis at 37°C for 120 min, and a
final inactivation step for 5 min at 95°C. The mRNA levels
were determined by quantitative real-time PCR analysis
using an ABI Prism 7900 HT Fast Real-Time PCR Sys-
tem (Applied Biosystems, Foster City, CA). Gene-
specific primer pairs and probes for GCLC and GCLM
(GCLM:Hs00157694_m1, GCLC:Hs00155249_m1,Assay-
on-demand, Applied Biosystems), were used together with
1x TaqMan® Universal PCR Master Mix (Applied Biosys-
tems, Foster City, CA) and 2 μL of reverse transcribed
sample RNA in 20 μL reaction volumes. PCR conditions
were 10 min at 95°C for enzyme activation, followed by 40
two-step cycles (15 sec at 95°C; 1 min at 60°C). The levels
of glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
expression were measured in all samples to normalize
gene expression for sample-to-sample differences in RNA
input, RNA quality and reverse transcription efficiency.
Each sample was analyzed in triplicate, and the expression
was calculated according to the 2-ΔΔCt method [22].
Redox biosensors experiments
Glutaredoxin-1 (Grx1) is an enzyme that specifically cat-
alyzes the equilibrium between the redox pair of interest,
reduced glutathione (GSH) and oxidized glutathione
(GSSG) in the cytoplasm. In this way, Grx1-roGFP2fusion protein allowed dynamic live imaging of the gluta-
thione redox potential in the cytoplasm with high sensitiv-
ity (from millimolar to nanomolar changes) and temporal
resolution, facilitating the observation of physiologically
relevant redox-based signals responding to exogenously
applied agents [23,24]. The Grx1-roGFP2 fusion protein
targeted to the mitochondrial matrix using a signal se-
quence from Neurospora crassa ATP synthase protein 9
(mito-Grx1-roGFP2) determines the glutathione redox
potential in mitochondria.
Retroviral supernatants from PA317 Grx1-roGFP2 and
mito-Grx1-roGFP2 lines (kindly donated by Dr. Santiago
Lamas, CIB) were collected and used for control and pa-
tients human keratinocytes infections (three controls and
three patients). Two rounds of seven hours infections
were performed and keratinocytes were grown until con-
fluence with keratinocyte medium (percentage of infection
was higher than 75%). GFP positive cells were analyzed by
flow cytometry (LSRFortessa, BD Biosciences, USA) either
in basal state or after addition of 12.5 μM hydrogen perox-
ide solution. Cells were excited with 405 and 488 nm la-
sers and the ratio of emissions in the green channel was
calculated. Flow cytometry data were analysed using
FlowJo version 7.6.1.
Western blotting
Keratinocytes were lysed with a lysis buffer prepared with
Tris pH 7.5 50 mM, NaCl 150 mM, Triton 1.5%, EDTA
1 mM, protease inhibitor cocktail tablets (Roche), ortova-
nadate, sodium pyrophosphate and sodium fluoride. The
lysates were then loaded with LDS Sample Buffer (Invitro-
gen) or manufactured sample buffer 5X and run on
NuPage 4–12% Bis-Tris gels (Invitrogen) at 120 V for
2 hours for antioxidant enzymes. The proteins were then
transferred onto nitrocellulose membranes (Invitrogen)
and blocked in 5% skimmed milk in 0.1% Tween-20
(Sigma-Aldrich) and phosphate-buffered saline. The mem-
branes were then probed with anti-kindlin1 (1:10.000)
antibody [25] overnight at 4°C. Mouse monoclonal anti-α
tubulin (Sigma-Aldrich) was used as loading control.
Anti-rabbit horseradish peroxidase-conjugated IgG anti-
body was used as secondary antibody. Visualization of
protein bands was done with ECL western blotting de-
tection reagents (Amersham Biosciences and Thermo
Scientific).
Confocal microscopy
The mitochondrial distribution and morphology was stud-
ied by confocal microscopy. Cells were plated in rounded
glass in Cnt-BM.1 medium and after 48 h of culture they
were stained to localize mitochondria and nuclei. Cells
were loaded with Mito Tracker Red™ (Invitrogen) in a final
concentration of 250 nM in cell culture medium, 37°C
and 5% CO2 and after 30 minutes of incubation they were
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was detected by confocal microscopy (A1 Confocal Laser
Microscope System (Nikon)) and the plane (along the Z
axes) that had most mitochondria was captured. Images
are representative examples of 3 separate experiments.
Mitocondrial’s membrane potential was determined
with JC-1™ vital dye (Invitrogen). It is a cationic dye that
exhibits potential-dependent accumulation in mitochon-
dria, indicated by a fluorescence emission shift from
green (~520 nm) to red (~590 nm). Consequently, mito-
chondrial depolarization is indicated by a decrease in the
red/green fluorescence intensity ratio. Cells were plated
in rounded glass in Cnt-BM.1 medium and after 48 h of
culture they were stained with 2.5 μg/mL JC-1™, 10 mi-
nutes, 37°C. After that, glasses were mounted with DAPI
and pictures were obtained with a confocal microscope.
Statistical analysis
For the statistical analysis of the results, the mean was
taken as the measurement of the main tendency, while
standard deviation was taken as the dispersion measure-
ment. A Student-Newman-Keuls method was used to
determine the significance of differences, when analyzing
GSSG/GSH ratio, GCLC and GCLM relative expression
determined by qRT-PCR, MDA levels studied by HPLC-
UV, biosensors by flow cytometry and JC-1 intensity by
confocal microscopy. The significance has been consid-
ered at *p < 0.05, **p < 0.01 and ***p < 0.001, as indicated
in each case. GraphPad Software v5.0 was used for stat-
istical analysis and graphic representations.
Results
FERMT1 mutations correlate with reduced or absent
kindlin-1 protein in KS keratinocytes
Three unrelated patients with KS were studied. The pa-
tients’ mutations, age and gender are summarized in
Additional file 1: Table S1. Clinical features and muta-
tions have been previously described; patients 4, 10 and
53 described in that study correspond respectively to
our patients SK1, SK2 and SK3 [16]. The effects of the
mutations were confirmed at mRNA and protein levels.
Patient 1 (SK1) presented a homozygous mutation within
the consensus sequence of the donor splice site of intron
11 (c.1371 + 4A >G) that was predicted to result in aber-
rant splicing of the FERMT1 pre-mRNA. This mutation
causes the skipping of 32 nucleotides leading to incorrect
processing of the mRNA that generates a prematurely
ending (truncated) protein. Consistently, the RT-PCR
analysis and the western blot indicated the presence of
truncated mRNA (data not shown) and protein (p.
Gln226ProfsX17) (Additional file 1: Figure S1). Patient
2 (SK2) presented a homozygous duplication at codon
676 (c.676dupC) leading to a frameshift that results in
the generation of a premature termination codon, 16codons downstream. Consistent with this prediction
the mRNA and protein analysis showed the presence of
a truncated message (data not shown) and absence of
protein (Additional file 1: Figure S1). Patient 3 (SK3)
presented a homozygous single nucleotide substitution
(T > C) at position 1198 in exon 10 (c.1198 T > C).
mRNA and protein analysis showed messenger (data
not shown) and protein of normal size (amino acid sub-
stitution: p.Ser400Pro [16]), although the amount of
kindlin-1 is markedly reduced as compared to control
keratinocytes (Additional file 1: Figure S1).
These patients represent a proper sampling of the
spectra of mutations found in KS, with one patient
showing total lack of expression (SK2), one presenting a
truncated protein (SK1) and a third expressing a normal
size protein with a single amino acid substitution and re-
duced expression (SK3).
Keratinocytes from KS patients are prone to oxidative
stress
GSH is one of the most important protective mechanisms
against ROS. In this regard, one of the best-characterized
biomarkers of cellular oxidative stress is the ratio between
oxidized and reduced glutathione (GSSG/GSH) [13-15].
The GSSG/GSH ratio was significantly higher in kerati-
nocytes from SK1 and SK3 patients than those obtained
from their matched (gender and age) healthy controls.
Keratinocytes from SK2 patient followed the same
trend, although differences were not statistically signifi-
cant (Figure 1a-c). Expression levels of the two subunits
of the gamma-glutamyl cysteine ligase (GCLC, the cata-
lytic subunit and GCLM, the modulatory subunit),
which catalyzes the first rate limiting step for the syn-
thesis of GSH were determined by quantitative PCR.
Results showed in Figure 1d-f, indicated that the
mRNA levels of GCLC were significantly reduced in KS
keratinocytes, as compared to their matched controls.
Decreased levels of the modulatory subunit (GCLM)
mRNA were also found in SK1 and SK3.
We also studied another marker of oxidative stress,
malondialdehyde (MDA). This is a product of the deg-
radation of polyunsaturated lipids by ROS [26]. Our re-
sults showed that all KS patient-derived keratinocytes
have higher MDA levels compared to their matched
control keratinocytes, indicating oxidative damage of
lipids (lipoperoxidation) in KS cells. Noteworthy, MDA
level values were higher in cells obtained from an adult
patient (SK3) than in the keratinocytes derived from the
young patients (SK1 and SK2) (Figure 1g-i).
In order to confirm the redox status alteration in KS
keratinocytes were transduced with a highly sensitive chi-
merical redox biosensor system (Grx1-roGFP2). A second
sensor containing a signal peptide directed to the mito-
chondria (mito-Grx1-roGFP2) was also used to detect
Figure 1 Oxidative stress profile in Kindler Syndrome Keratinocytes. (a-c) GSSG/GSH ratio as redox profile coefficient was measured by
fluorimetry in keratinocytes from patients SK1 (a), SK2 (b), and SK3 (c) and their matched controls. (d-f) GCLC and GCLM gene expression was
analyzed by qPCR using GAPDH as reference gene in SK1 (d), SK2 (e), and SK3 (f) and their matched controls, using the method 2-ΔΔCt. (g-i)
Malondialdehyde (MDA) levels were measured by HPLC-UV in SK1 (g), SK2 (h), and SK3 (i) and their matched controls. Results represent the means
and SD from two independent experiments in triplicate samples. *p < 0.05: statistically significant difference from control value, after t-student test.
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trol keratinocytes expressing Grx1-roGFP2 or mito-Grx1-
GFP2 were treated with hydrogen peroxide solution
(H2O2) and analyzed by flow cytometry. The basal biosen-
sor levels in the KS keratinocytes (in the absence of H2O2)
already showed a higher oxidized/reduced ratio than their
respective controls. After H2O2 challenge, the same ten-
dency was observed, indicating a higher pro-oxidative
state in KS keratinocytes (Figure 2a). When the mitochon-
drial redox status was analyzed using mito-Grx1-roGFP2,
a similar response to that found at the cytoplasm was ob-
served (Figure 2b). Only patient 3 showed similar re-
sponses to the controls (Additional file 1: Figure S2). This
could be likely due to the mild nature of the FERMT1mu-
tation in this patient which explains also the moderate
symptoms described in this patient.
Mitochondrial structure, localization and function is
altered in KS epidermis and keratinocytes in culture
We sought to determine whether deranged redox status
could translate into ultrastructural changes in target or-
ganelles. For this purpose, the morphology of mitochon-
dria in patient skin biopsies and cultured keratinocytes
was analyzed by electron microscopy. The Figure 3ashows a panoramic view of the KS epidermis, showing a
zoom in a basal keratinocyte (Figure 3b). The ultra-
structural analysis of KS skin biopsies revealed striking
abnormalities in mitochondria. In fact, mitochondrial
crests were irregular, dilated and did not present paral-
lel distribution (Figure 3c), which contrasted with the
well-organized mitochondrial network in normal skin
biopsies (Figure 3d). Furthermore, both internal and ex-
ternal mitochondrial membranes had a wavy morph-
ology and irregular thickness (Figure 3c). Similarly, the
ultrastructural analysis of the cultured keratinocytes from
KS patients showed mitochondrial alterations with a
tendency toward the fusion of mitochondrial crests
that may affect the inter-membrane space and func-
tionality (Figure 3f ) compared with control keratino-
cytes (Figure 3e). To analyze mitochondrial distribution,
keratinocytes from healthy subjects and KS patients were
incubated with the mitochondria-specific dye Mito
Tracker Red and subsequently analyzed by confocal mi-
croscopy. Mitochondria in control keratinocytes formed
a well-established network. In contrast, keratinocytes
from KS patients showed both, a reduced and diffuse
Mito Tracker Red staining consistent with a disorganized
mitochondrial network (Figure 4a and b). In order to
Figure 2 Redox biosensor experiments. (a and b) Retroviruses encoding either Grx1-roGFP2 (a) or mito-Grx1-roGFP2 (b) cDNAs were used to
infect KS patients and control keratinocytes. The Ratio 405/488 nm was calculated in basal state and when H2O2 solution was added to the cells
(12.5uM). KS patients present higher ratios than controls even at a basal state (without H2O2 solution), indicating a higher oxidized state in both
cytoplasmic and mitochondria compartments. Average values of each experimental group are shown. *p < 0.05, **p < 0.01: statistically significant
difference from control value, after t-student test.
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was studied in control and KS keratinocytes using the
JC-1 probe. The analysis showed a significant reduction
of the membrane potential in KS cells compared to
controls as determined by the red-to-green JC-1 dye shift
(Figure 4c-e and Additional file 2: Figure S3). Overall, our
data indicate that mitochondria in KS keratinocytes are
not only altered in structure, but also in their distribution
and functionality.
Discussion
The natural history of a genetic disease is not completely
described by the simple identification of the causal muta-
tion but requires also the understanding of biochemical
and molecular mechanisms that are directly responsible of
the phenotypic characteristics of the disease. Sometimes
this is challenging given the multiple interactions of genes
downstream of the mutation. This appears to be the case
of KS for which several aspects of its pathogenesis remainuncertain. Since two of the unexplained features of KS,
photosensitivity and cancer development, have been asso-
ciated with oxidative stress, we have advanced the hypoth-
esis that some clinical features of KS patients may be
related to a redox imbalance and higher susceptibility to
oxidative stress.
Our results cover mutation spectra and phenotype since
they are based on three very different types of mutations.
They include a simple hypomorphic mutation caused by a
single amino acid substitution (SK3), a mutation resulting
in a truncated protein (SK1), and a patient null for
kindlin-1 (SK2). Furthermore, given the importance of age
in the symptomatology of this disease, the three patients
studied reflect different ages, two children (SK1 and SK2)
and one adult (SK3). For redox studies, we also took into
account the patients’ gender (all patients are females) and
consequently, in every case the control was matched by
age and gender. As for other genodermatoses, availability
of samples to derive keratinocyte cultures is usually low.
Figure 3 Mitochondrial ultrastructure in KS. Keratinocytes from skin biopsies and cultured keratinocytes from control and KS patients were
studied by electron microscopy (EM). (a) Panoramic view of the basal stratum from SK3 patient. (b) Detail of a keratinocyte (squared region in a).
(c) Mitochondria from patient SK3 (squared in b). (d) Mitochondria from a control sample. (e,f) EM photomicrographs of mitochondria from
control (e) and from patient SK1 (f) cultured keratinocytes. Scale bars: 10 μm (a), 2 μm (b), 200 nm (c, d, e, f). Images shown are representative
of each experimental group.
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mary patient cells covering different mutations and ages,
follow a clear trend regarding oxidative status and mito-
chondrial alterations.
The oxidative stress biomarker analysis revealed that
GSSG/GSH ratio was higher in SK1 and SK3 keratino-
cytes (Figure 1). These results are linked to a lower
capability of KS cells to synthesize GSH due to the down-
regulation of the catalytic (GCLC) and the regulatory(GCLM) subunits of gamma-glutamyl cysteine ligase
(GCL), the first rate limiting enzyme of GSH synthesis
(Figure 1). Therefore, keratinocytes from KS patients
are prone to oxidative stress likely leading to damage of
different cellular components. Consistently, the lipoper-
oxidation product MDA showed high levels in KS kera-
tinocytes. In addition, this difference was higher in cells
from the adult patient (Figure 1). These results, which
may reflect oxidative damage accumulation during ageing,
Figure 4 Mitochondria distribution and function in KS keratinocytes. (a and b) Mito Tracker Red staining. Note the smeared mitochondria
staining in KS keratinocytes (b) as compared to the control cells (a). (c and d) JC-1 staining. Note mitochondrial depolarization in KS keratinocytes
as indicated by the decrease in the red/green fluorescence intensity ratio. (e) Quantification of JC-1 staining. Membrane potential reduction was
statistically significant (*p < 0.05) after t-student test. Scale bars = 10 μm.
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volved in the pathogenesis of skin alterations associated
with non-melanoma and melanoma skin cancer [27] as
well as photoaging [28]. Furthermore, MDA can bind
to DNA producing mutagenic adducts [29]. MDA de-
rivatives such as dihydropyridine (DHP)-type adducts
including DHP-sysine [(S)-2-amino-6-(3,5-diformyl-4-
methyl-4 h-pyridin-1-yl)-hexanoic acid] may accumu-
late under cellular redox unbalance in human tissues
[30,31]. These products can originate phototoxicity as
occurs in human retinal pigment epithelial cells [32]
and could be major sensitizers of photooxidative stress
in human skin cells [33].
Cytoplasmic and mitochondrial abnormalities in redox
balance confirmed by Grx1-roGFP2 biosensors system,
in KS keratinocytes (Figure 2) suggests that KS cells
would not be competent to properly cope with an oxida-
tive imbalance in these compartments.
Taken together, our results suggest that alterations of
the redox balance in KS may be a potential explanation
of the premature skin ageing and cancer prone pheno-
type of these patients.
As discussed above, our results with the biosensor
probes point to the cytoplasm and the mitochondria as
potential sources of ROS. For this reason, we decided to
study morphological and functional alterations of the
mitochondria of KS patients. Electron microscopy of both,skin biopsies and cultured keratinocytes from KS patients
showed morphological alterations which are consistent
with dysfunctional mitochondria (Figure 3) as previously
described in UV-irradiated skin [34]. These results were
confirmed by confocal microscopy which not only showed
morphological alterations with the Mito Tracker probe
but also functional abnormalities as revealed by the mem-
brane potential-sensitive JC-1 dye (Figure 4). Similar re-
sults were reported with these two probes in studies of
mitochondrial dysfunction in Parkinson's and Alzheimer's
disease [35,36].
To our best knowledge, neither oxidative stress nor al-
terations in the mitochondria have been previously re-
ported in KS. It is not yet clear whether a derangement
of the redox status in KS cells is cause or consequence
to mitochondrial dysfunction and morphological aberra-
tions. The most likely explanation is that mitochondria
are both the cause and effect of the oxidative stress.
Therefore, we envisage a vicious circle where ROS-
altered mitochondria results in increased mitochondrial
oxidative stress.
At this point it is not clear how alterations in kindlin-
1 may lead to generation of oxidative stress. It is unlikely
that the pure disruption of the kindlin-1 synthesis would
explain this phenomenon. A likely explanation is that al-
terations in kindlin-1 function lead to a disruption in the
signal transduction pathways involving integrins and
Zapatero-Solana et al. Orphanet Journal of Rare Diseases  (2014) 9:211 Page 9 of 10focal adhesions [37-40]. In fact, integrins modulate mito-
chondrial function by signalling through Rho GTPases
leading to the increase in ROS formation. On the other
hand, ROS play a role in the regulation of the early
phase contact between integrins and extracellular matrix
resulting in a positive feedback loop [39]. Not only mito-
chondrial ROS but also cytosolic ROS levels are affected
by integrins, particularly in cooperation with growth factor
stimulation [41,42]. Recent evidence from a conditional
Fermt1 knock out mouse model associated kindlin-1 defi-
ciency to αv β6 integrin-mediated increase of TGFβ ac-
tivation [40]. It has been shown that TGFβ-induced
reduction of mitochondrial complex IV and respiration
leads to increased ROS and decreased mitochondrial
membrane potential associated with senescence in lung
epithelial cells. TGFβ-1 induces prolonged mitochon-
drial ROS generation through decreased complex IV ac-
tivity with senescent arrest in Mv1Lu cells [43]. It is
thus tempting to speculate that these molecular events
may be related to the oxidative stress and mitochon-
drial changes herein described. Further studies are,
however, needed to establish whether TGFβ could be
the link between deficient integrin signalling and oxida-
tive stress.
Conclusions
Our results suggest that KS keratinocytes are cells under
severe oxidative stress, a condition which could underlie
some of the obscure aspects of the disease such as pho-
toaging, photosensitivity and ultimate, the high risk of
cancer development.
Additional files
Additional file 1: Table S1. Age and sex description of the patients and
controls used in this study. Figure S1. Expression analysis of Kindlin1 is
KS keratinocytes. Western blot analysis was performed from control and
KS keratinocytes. Cells from each patient show a different pattern of
protein expression due to their different FERMT1 mutations. α-tubulin was
used as protein loading control. Figure S2. Patient specific redox biosensors
analysis. The ratio 405/488 nm in control and KS keratinocytes from
each patient infected either with retroviruses encoding Grx1-roGFP2 (a)
or mito-Grx1-roGFP2 (b) are shown.
Additional file 2: Figure S3. Quantification of JC-1staining by FACS
analysis. Note mitochondrial depolarization in KS keratinocytes compared
with their respective controls, as indicated by the decrease in the red/green
fluorescence intensity ratio. Membrane potential reduction was statistically
significant (*p < 0.05) after t-student test.
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